Y-mAbs Therapeutics, Inc.

GOLDMAN SACHS GROUP INC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

212,751

Value ($000)

960

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	960	0.0%	212,751	6/30/2025
2025 Q1	6/27/2025	894	0.0%	201,776	3/31/2025
2024 Q4	2/11/2025	1,716	0.0%	219,175	12/31/2024
2024 Q3	11/14/2024	2,927	0.0%	222,600	9/30/2024
2024 Q2	8/13/2024	1,676	0.0%	138,739	6/30/2024
2024 Q1	5/15/2024	5,944	0.0%	365,536	3/31/2024
2023 Q4	5/14/2024	2,714	0.0%	397,951	12/31/2023
2023 Q3	5/15/2024	2,122	0.0%	389,347	9/30/2023
2023 Q2	5/14/2024	2,734	0.0%	402,651	6/30/2023
2023 Q1	5/14/2024	956	0.0%	190,791	3/31/2023
2022 Q4	5/14/2024	1,546	0.0%	316,852	12/31/2022
2022 Q3	5/14/2024	2,640	0.0%	183,077	9/30/2022
2022 Q2	5/14/2024	2,296	0.0%	151,726	6/30/2022
2022 Q1	5/16/2022	1,498	0.0%	126,111	3/31/2022
2021 Q4	2/17/2022	3,523	0.0%	217,361	12/31/2021
2021 Q3	1/20/2022	23,213	0.0%	813,355	9/30/2021
2021 Q2	8/13/2021	27,733	0.0%	820,482	6/30/2021
2021 Q1	5/17/2021	24,732	0.0%	817,849	3/31/2021
2020 Q4	2/12/2021	42,650	0.0%	861,438	12/31/2020
2020 Q3	11/13/2020	27,876	0.0%	726,117	9/30/2020
2020 Q2	8/12/2020	25,050	0.0%	579,878	6/30/2020
2020 Q1	5/15/2020	12,910	0.0%	494,641	3/31/2020
2019 Q4	2/14/2020	18,026	0.0%	576,846	12/31/2019